Urban Supreme System

Nowadays, although medicines produced by the Zongguo are everywhere abroad, only the medicines produced by the Zongguo are almost unavailable abroad.

For my country's pharmaceutical industry, drug research and development has always been a tangled topic.

Although in recent years, driven by policies and markets, the concentration of my country's pharmaceutical industry has increased, and the level of drug research and development has also begun to improve to a certain extent, the overall level of my country's pharmaceutical industry is not as good as that of countries with mature R\u0026D systems. The gap is still very large.

At present, the number of innovative drugs with completely independent intellectual property rights in China is very small, and the only innovative drugs have no market abroad. There are very few domestic pharmaceutical companies that have really gone abroad, and most of them are only domestically produced. The market is just for survival.

However, innovative drugs developed by foreign pharmaceutical companies are very popular in the domestic market. This is a very regrettable and sad thing.

But now Changhua Pharmaceutical has changed this situation. Not only has the drug been sold in foreign markets, but the sales volume is also very high. The supply is basically in short supply, and agents have come over again and again to rush for the goods.

As a member of Changhua Pharmaceutical, Li Changhua would naturally feel proud and elated about this.

"Agents also hope that we can increase supply so that they can get more drugs to sell." Li Changhua continued.

This is also very normal. When agents see that the sales of these drugs are so good, of course they hope to get more shipments so that they can make more money.

However, with the current output of Changhua Pharmaceutical, it is impossible to increase the supply volume.

This is only possible unless Changhua Pharmaceutical's production can be increased.

But so far. Changhua Pharmaceutical did not provide production volume plans. And even if Changhua Pharmaceutical has plans to increase production. It will not increase the agent's supply.

"It is impossible to increase supply. Even if we increase production, we must first increase agents." Su Zhe said.

In Su Zhe's plan, even if the output is increased, he will find another agent and first develop the market in other countries, rather than increasing the supply of current agents.

Because the volume of goods obtained by these agents can barely meet the needs of their countries.

And Changhua Pharmaceutical wants to provide international influence. We cannot limit the market to a few countries, but try to develop other countries so that the drugs can be sold to as many countries as possible.

Therefore, Su Zhe has no plans to increase supply to current agents. Even if Changhua Pharmaceutical's production increases in the future, he will only look for agents in other countries to deliver the newly increased production to other countries. agent sales.

Li Changhua and Liu Xiong both nodded. They also knew the current strategic goals of Changhua Pharmaceutical, so they responded to Su Zhe's words. No objection was raised.

But Su Zhe also thought about the current production pressure in the factory. It's getting bigger and bigger.

Even after the acquisition of Guanzhou Xinjing Pharmaceutical, facing the rapidly increasing production plan, the current production capacity of Changhua Pharmaceutical gradually began to be unable to cope with it.

But before that, Li Changhua and the others had deployed a series of plans, such as increasing production lines, expanding the pharmaceutical factory and the new branch of Guanzhou Xinjing Pharmaceutical, all in preparation for increasing production capacity.

The plan is divided into several phases. Once all are implemented, the production capacity of Changhua Pharmaceutical can be more than doubled, or even increased several times.

After all, both Changhua Pharmaceutical Factory and Guanzhou Xinjing Pharmaceutical have a lot of vacant land that has not yet been utilized.

If all these open spaces are used to build a new branch factory and install new production lines, the production capacity of Changhua Pharmaceutical will definitely be greatly improved.

However, this cannot be accomplished in a short time, it will take a lot of time to achieve.

Changhua Pharmaceutical's production plan has been increased several times in a short period of time.

Although Changhua Pharmaceutical's current production capacity can still cope with it, if it increases production further, the production capacity will be close to saturation, and it will be difficult to meet the new production plan.

But the new expansion plan cannot be completed so quickly.

This is one of the problems that Changhua Pharmaceutical needs to face in its current development. Improving production capacity is a top priority.

Su Zhe did not expect that Changhua Pharmaceutical's production capacity would approach the limit so quickly.

Originally, Su Zhe thought that after acquiring Guanzhou Xinjing Pharmaceutical, Changhua Pharmaceutical's production capacity would no longer have to worry about for a long time.

But not long after the acquisition, Changhua Pharmaceutical now needs to face this problem again.

This is something Su Zhe didn't expect, but this is also Changhua Pharmaceutical's production plan. It has been increased too much, so the current production capacity has reached the limit so quickly.

However, this also shows that Changhua Pharmaceutical is developing rapidly, and the drugs it launches are very popular in the market, so the production capacity cannot keep up, and supply exceeds demand.

Overall, this is a good thing for Changhua Pharmaceutical.

But Su Zhe and the others now need to discuss the issue of increasing production capacity.

It is still the same as before, the old method is to accelerate the expansion of Changhua Pharmaceutical's new pharmaceutical factory, and at the same time, it also begins to identify pharmaceutical factories suitable for acquisition to increase the production capacity of Changhua Pharmaceutical.

This is the plan that Su Zhe and Li Changhua came up with after consultation, and this is the only way they can do it now.

In general, it is a good thing that Changhua Pharmaceutical's production plan has been increased several times in a short period of time. This also indirectly shows that Changhua Pharmaceutical is developing faster and faster, and the market is now interested in it. The demand is also getting bigger and bigger.

This is what Su Zhe and the others expected from Changhua Pharmaceutical. Now that they have achieved this, they are naturally very happy.

Things that need to be discussed have now been discussed, and things that need to be explained have been given instructions.

Therefore, today's meeting is over here.

Although Li Changhua and Liu Xiong didn't know what method Su Zhe used to obtain the formula of Joint Spirit, although they were very curious, they didn't ask.

Everyone has their own secrets that they don't want others to know, so if Su Zhe didn't take the initiative to tell them, Li Changhua and Liu Xiong wouldn't ask.

Anyway, Su Zhe handed over the formula of Joint Spirit to Changhua Pharmaceutical for development, which would be beneficial to everyone.

Therefore, both Li Changhua and Liu Xiong believed that there was no need to ask about some things, lest they destroy their mutual trust.

This is the way Li Changhua and Liu Xiong deal with it, and this is also their attitude towards their collaborators.

In this way, Su Zhe was relieved a lot, at least he didn't have to think of ways to explain the origin of the joint spirit. (To be continued...)

...

... ()